Article
Harnessing innate immune pathways for therapeutic advancement in cancer
25 Mar 2024
Abstract excerpt
The innate immune pathway is receiving increasing attention in cancer therapy. This pathway is ubiquitous across various cell types, not only in innate immune cells but also in adaptive immune cells, tumor cells, and stromal cells. Agonists targeting the innate immune pathway have shown profound changes in the tumor microenvironment (TME) and improved tumor prognosis in preclinical studies. However, to date, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
